abt-888
Showing 1 - 14 of 14
Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)
Active, not recruiting
- Breast Cancer
- +3 more
- ABT-888
- temozolomide
-
Boston, Massachusetts
- +2 more
Dec 21, 2022
Medulloblastoma, Pontine Glioma, Ependymoma Trial run by the NCI (Temozolomide, ABT-888)
Completed
- Medulloblastoma
- +4 more
- Temozolomide
- ABT-888
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 6, 2019
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Colorectal Cancer Trial in Washington (Temozolomide, ABT-888)
Completed
- Colorectal Cancer
- Temozolomide
- ABT-888
-
Washington, District of ColumbiaGeorgetown University Medical Center
Mar 10, 2019
Ovarian Cancer Trial in Worldwide (ABT-888, pegylated liposomal doxorubicin, temozolomide)
Completed
- Ovarian Cancer
- ABT-888
- +2 more
-
Duarte, California
- +31 more
Jun 1, 2018
Non-hematologic Malignancies, Metastatic Melanoma, Breast Cancer Trial (ABT-888, Temozolomide)
Completed
- Non-hematologic Malignancies
- +6 more
- ABT-888
- Temozolomide
- (no location specified)
Nov 17, 2017
Brain Diseases, Brain Tumors, CNS Diseases Trial in Canada, Puerto Rico, United States (ABT-888, Whole Brain Radiation Therapy)
Completed
- Brain Diseases
- +4 more
- ABT-888
- Whole Brain Radiation Therapy
-
Atlanta, Georgia
- +8 more
Nov 17, 2017
Solid Tumors, Lymphomas Trial run by the NCI (ABT-888, Topotecan)
Completed
- Solid Tumors
- Lymphomas
- ABT-888
- Topotecan
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Tumors Trial in Bethesda, Pittsburgh (ABT-888, Carboplatin, Paclitaxel)
Withdrawn
- Neoplasms
- ABT-888
- +2 more
-
Bethesda, Maryland
- +1 more
Jun 30, 2017
Hepatocellular Carcinoma Trial in Washington (Temozolomide, ABT-888)
Terminated
- Hepatocellular Carcinoma
- Temozolomide
- ABT-888
-
Washington, District of ColumbiaLombardi Comprehensive Cancer Center at Georgetown University Me
Mar 11, 2017